Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Interested in exploring the world of Group Compliance? Curious about working in a stimulating and challenging environment of a multinational company? We are looking for a talent with a positive can-do attitude who is able to
#Boston Scientific For 40 years, Boston Scientific, a world-leading medical technology company, has been working towards the goal of improving patients’ lives. Every day, we tackle the healthcare industry’s most significant challenges with innovative products, a
Job Title: MSF Access Policy Advisor - Economic Policies Contract: Full time (100%) Duration: 1 year Starting Date: September 2026 Location: Any MSF Office Deadline to apply: July 28, 2026 Reports to: Head of Analysis Compensation and
The story of Cartier is founded on audacity and passion. For more than 170 years we have embraced a bold, pioneering spirit that continues to inspire our teams across all Métiers from our boutiques to our
Would you like to shape the future of Life & Health reinsurance in Italy? This is your opportunity to take on a strategically pivotal role at Swiss Re — one where actuarial excellence meets commercial leadership,
Company Description At Intuitive, we are united behind our mission: we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints. As a
We are recruiting a Market Access & Pricing Lead based at our global headquarters in Meyrin, Switzerland. Reporting directly to the Head of Business Development & Alliance Management and as part of a team of three, your
Specialist, Large-Scale Industrial Technology Adoption The World Economic Forum, committed to improving the state of the world, is the international organization for public-private cooperation. The Forum engages the foremost political, business and other leaders of society to
At Swarovski, you don’t just join a brand - you help reinvent one of the most iconic names in fashion and design. Here, bold ideas matter, creativity drives change, collaboration is valued, and your work shapes
At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create,
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
SIX drives the transformation of financial markets. What sets us apart drives us ahead: between local roots and global relevance, we are a unique blend of tradition and future, of foundation and growth. We value bright minds
Country Switzerland City GENEVE Workplace location GENEVE-WTC1(CHE) Employer company TOTSA TotalEnergies Trading SA Domain Finance Type of contract Regular position Experience Minimum 3 years Context & Environment TotalEnergies has developed a strong expertise in oil and
Working closely with Global Support TA&A management and the TA&A community, you will be in charge of: Defining and maintaining a structured TA&A knowledge management framework aligned with global standards and local specificities. Capturing, organizing, and disseminating
Position Summary/Purpose The HR Business Partner works closely with management to drive measurable improvements in employee engagement and productivity. This role builds strong partnerships across the HR function to deliver value added services to both management
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Ripple, we’re building a world where value moves like information does today. It’s big, it’s bold, and we’re already doing it. Through our crypto solutions for financial institutions, businesses, governments and developers, we are improving
About This Role: As the Lead Value and Access for Switzerland and Austria, you will play a pivotal role in designing and implementing strategies to maximize the value recognition of our drug portfolio among payors. You